|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Novel platform linking cancer-specific glycosylation with cell signaling outcomes
|
1R21CA229044-01
|
$225,250
|
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NP
|
5R01CA115873-03
|
$1
|
$1
|
ADAMI, HANS-OLOV
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
University of North Carolina Womens Interagency HIV Study UNC WIHS
|
3U01AI103390-05S1
|
$60,652
|
|
ADIMORA, ADAORA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
5R03CA212798-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Genetics of Graft-versus-Host Disease
|
1R01CA231141-01
|
$265,229
|
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-05
|
$382,616
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Genomewide association in early-onset breast cancer
|
5U01CA122171-05
|
$754,460
|
$754,460
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Dr. Keiko Akagi, A Bioinformatics Specialist in Cancer Genomics Research at OSU Comprehensive Cancer Center
|
5R50CA211533-03
|
$122,475
|
|
AKAGI, KEIKO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Metabolic Syndrome and Epigenetic Markers of Breast Cancer in Nigerian Women
|
5K01TW010271-03
|
$134,531
|
|
AKINYEMIJU, TOMI
|
UNIVERSITY OF KENTUCKY
|
|
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
|
1P01CA217805-01A1
|
$2,105,511
|
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-04
|
$1,855,117
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$133,226
|
$133,226
|
Ambs, Stefan
|
CCR (NCI)
|
|
Development of first-in-class histone acetyltransferase (HAT) activators for precision targeting of epigenetic derangements in lymphoma
|
1R01CA222931-01A1
|
$370,575
|
|
AMENGUAL, JENNIFER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
1U19CA148127-01
|
$2,818,904
|
$2,452,446
|
AMOS, CHRISTOPHER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Functional Contribution of Metabolic Complex to Cancer Cell Metabolism
|
1R03CA219609-01A1
|
$72,194
|
|
AN, SONGON
|
UNIVERSITY OF MARYLAND BALT CO CAMPUS
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Steroid hormone regulation of immune responses
|
1R01CA229400-01
|
$384,018
|
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-16
|
$651,917
|
$651,917
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
Predictive signatures in breast cancer using multiplexed ion beam imaging
|
5DP5OD019822-05
|
$401,249
|
|
ANGELO, ROBERT
|
STANFORD UNIVERSITY
|
|
Cancer Metabolism Training Program
|
1T32CA221709-01A1
|
$201,444
|
|
ANN, DAVID
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
|
2R01CA160495-06A1
|
$370,500
|
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical Trials
|
1K08CA230306-01
|
$254,821
|
|
ARISTIZABAL, PAULA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Targeting DOT1L for Degradation in MLL-rearranged Leukemia
|
2R01CA176745-07
|
$404,076
|
|
ARMSTRONG, SCOTT
|
DANA-FARBER CANCER INST
|
|
Racial Differences in BRCA1/2 Testing: Patients or Providers?
|
5R01CA133004-02
|
$570,178
|
$570,178
|
ARMSTRONG, KATRINA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
|
1R01CA231219-01
|
$444,969
|
|
ARONSON, WILLIAM
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$503,334
|
$251,667
|
Arthur, Diane
|
CCR (NCI)
|
|
Dual Targeting Redox?active Gold(I) Therapeutics
|
1R15CA232765-01
|
$462,195
|
|
ARUMUGAM, KUPPUSWAMY
|
WRIGHT STATE UNIVERSITY
|
|
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
|
1R01CA230516-01
|
$564,655
|
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$159,088
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting Nodal/TGF-Beta pathway to inhibit invasion and growth of retinoblastoma
|
1R21CA229919-01
|
$213,694
|
|
ASNAGHI, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Nutritionally Driven Sporadic Intestinal Tumors: Impact on Stem Cells
|
1R01CA229216-01
|
$493,238
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Familial Gastric Cancer: Diagnosis, DNA Sequencing, Early detection
|
ZIA BC 011341
|
$99,147
|
$99,147
|
Avital, Itzhak
|
CCR (NCI)
|
|
Nutrient Sensing and Transcriptional Regulation
|
1R01CA222650-01A1
|
$391,980
|
|
AYER, DONALD
|
UNIVERSITY OF UTAH
|
|
Integrative framework for identifying dysregulated mechanisms in the tumor-immune microenvironment
|
1K99CA230195-01
|
$134,632
|
|
AZIZI, ELHAM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
|
5F99CA222722-02
|
$39,707
|
|
BABATUNDE, OLUWOLE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Novel ODC Inhibitor Phaseolotoxin in Neuroblastoma
|
1R21CA216867-01A1
|
$193,750
|
|
BACHMANN, ANDRE
|
MICHIGAN STATE UNIVERSITY
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Improving Informal Caregivers and Cancer Survivors Psychological Distress, Symptom Management and Health Care Use
|
1R01CA224282-01A1
|
$650,204
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
Inter-relationship between microbiota diversity, obesity and race in endometrial cancer
|
5R21CA220269-02
|
$169,106
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
|
1R37CA218413-01A1
|
$414,368
|
|
BANSAL, AASTHAA
|
UNIVERSITY OF WASHINGTON
|
|
Implementation and Impact of Cancer Screening Navigation by Community Health Workers in Two National Screening Programs
|
1K01CA229996-01
|
$154,723
|
|
BARRINGTON, WENDY
|
UNIVERSITY OF WASHINGTON
|
|
Epigenomic and transcriptomic markers of aggressive prostate cancer among African American men
|
1K07CA230182-01
|
$138,094
|
|
BARRY, KATHRYN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Bioinformatic Analysis of Next Generation Sequencing Data from Cancer Cells
|
5R50CA221848-02
|
$173,980
|
|
BARTOM, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Molecular and Imaging Assessment of Fallopian Tube Health
|
1R21CA229707-01
|
$188,966
|
|
BARTON, JENNIFER
|
UNIVERSITY OF ARIZONA
|
|
U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA217685-02
|
$1,813,624
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Genetic Testing for this search: $122,915,276
|